BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30949410)

  • 1. Magnetic resonance imaging monitoring therapeutic response to dendritic cell vaccine in murine orthotopic pancreatic cancer models.
    Pan L; Shang N; Shangguan J; Figini M; Xing W; Wang B; Sun C; Yang J; Zhang Y; Hu S; Ma Q; Wang J; Velichko Y; Yaghmai V; Benson AB; Zhang Z
    Am J Cancer Res; 2019; 9(3):562-573. PubMed ID: 30949410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic dendritic cell vaccination controls pancreatic cancer growth in a mouse model.
    Shangguan A; Shang N; Figini M; Pan L; Yang J; Ma Q; Hu S; Eresen A; Sun C; Wang B; Velichko Y; Yaghmai V; Zhang Z
    Cytotherapy; 2020 Jan; 22(1):6-15. PubMed ID: 32005355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cell immunotherapy induces anti-tumor effect in a transgenic mouse model of pancreatic ductal adenocarcinoma.
    Yang J; Hu S; Shangguan J; Eresen A; Li Y; Pan L; Ma Q; Velichko Y; Wang J; Hu C; Yaghmai V; Zhang Z
    Am J Cancer Res; 2019; 9(11):2456-2468. PubMed ID: 31815046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pancreatic tumor-specific biomarker characterized in humans and mice as an immunogenic onco-glycoprotein is efficient in dendritic cell vaccination.
    Collignon A; Perles-Barbacaru AT; Robert S; Silvy F; Martinez E; Crenon I; Germain S; Garcia S; Viola A; Lombardo D; Mas E; Béraud E
    Oncotarget; 2015 Sep; 6(27):23462-79. PubMed ID: 26405163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic effects of treatment of pancreatic carcinoma by interleukin-23 and apoptotic cell antigen-modified dendritic cell vaccine: experiment with mice].
    Tan G; Wang ZY; Yin S
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):943-6. PubMed ID: 16759530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of antitumor immunity of dendritic cells pulsed with heat-treated tumor lysate in murine pancreatic cancer.
    Kim HS; Choo YS; Koo T; Bang S; Oh TY; Wen J; Song SY
    Immunol Lett; 2006 Mar; 103(2):142-8. PubMed ID: 16313973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratumoral immunization with tumor RNA-pulsed dendritic cells confers antitumor immunity in a C57BL/6 pancreatic murine tumor model.
    Schmidt T; Ziske C; Märten A; Endres S; Tiemann K; Schmitz V; Gorschlüter M; Schneider C; Sauerbruch T; Schmidt-Wolf IG
    Cancer Res; 2003 Dec; 63(24):8962-7. PubMed ID: 14695214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of route of administration on the efficacy of dendritic cell vaccine in PDAC mice.
    Yang J; Eresen A; Shangguan J; Ma Q; Zhang Z; Yaghmai V
    Am J Cancer Res; 2020; 10(11):3911-3919. PubMed ID: 33294276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of established pancreatic cancers following specific active immunotherapy with interleukin-2 gene-transduced tumor cells.
    Clary BM; Coveney EC; Philip R; Blazer DG; Morse M; Gilboa E; Lyerly HK
    Cancer Gene Ther; 1997; 4(2):97-104. PubMed ID: 9080118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
    Yasuda T; Kamigaki T; Nakamura T; Imanishi T; Hayashi S; Kawasaki K; Takase S; Ajiki T; Kuroda Y
    Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cell gene therapy.
    Onaitis M; Kalady MF; Pruitt S; Tyler DS
    Surg Oncol Clin N Am; 2002 Jul; 11(3):645-60. PubMed ID: 12487060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superior anti-tumor protection and therapeutic efficacy of vaccination with dendritic cell/tumor cell fusion hybrids for murine Lewis lung carcinoma.
    Chen X; Liu Z; Huang Y; Li R; Zhang H; Dong S; Ge C; Zhang Z; Wang Y; Wang Y; Xue Y; Li Z; Song X
    Autoimmunity; 2014 Feb; 47(1):46-56. PubMed ID: 24191684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cells based immunotherapy.
    Shang N; Figini M; Shangguan J; Wang B; Sun C; Pan L; Ma Q; Zhang Z
    Am J Cancer Res; 2017; 7(10):2091-2102. PubMed ID: 29119057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcosine promotes trafficking of dendritic cells and improves efficacy of anti-tumor dendritic cell vaccines via CXC chemokine family signaling.
    Dastmalchi F; Karachi A; Yang C; Azari H; Sayour EJ; Dechkovskaia A; Vlasak AL; Saia ME; Lovaton RE; Mitchell DA; Rahman M
    J Immunother Cancer; 2019 Nov; 7(1):321. PubMed ID: 31753028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Specific immune against pancreatic cancer induced by dendritic cells pulsed with mutant K-ras peptide].
    Yang B; He Y; Sun DL; Zou Y; Qin XH; Huang BH
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1956-60. PubMed ID: 19062734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cell-based immunotherapy targeting Wilms' tumor 1 in patients with recurrent malignant glioma.
    Sakai K; Shimodaira S; Maejima S; Udagawa N; Sano K; Higuchi Y; Koya T; Ochiai T; Koide M; Uehara S; Nakamura M; Sugiyama H; Yonemitsu Y; Okamoto M; Hongo K
    J Neurosurg; 2015 Oct; 123(4):989-97. PubMed ID: 26252465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cell-based vaccination: powerful resources of immature dendritic cells against pancreatic adenocarcinoma.
    Collignon A; Silvy F; Robert S; Trad M; Germain S; Nigri J; André F; Rigot V; Tomasini R; Bonnotte B; Lombardo D; Mas E; Beraud E
    Oncoimmunology; 2018; 7(12):e1504727. PubMed ID: 30524902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cells transduced with tumor-associated antigen gene elicit potent therapeutic antitumor immunity: comparison with immunodominant peptide-pulsed DCs.
    Nakamura M; Iwahashi M; Nakamori M; Ueda K; Ojima T; Naka T; Ishida K; Yamaue H
    Oncology; 2005; 68(2-3):163-70. PubMed ID: 16006753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of 2-arachidonoylglycerol in the regulation of the tumor-immune microenvironment in murine models of pancreatic cancer.
    Qiu C; Yang L; Wang B; Cui L; Li C; Zhuo Y; Zhang L; Zhang S; Zhang Q; Wang X
    Biomed Pharmacother; 2019 Jul; 115():108952. PubMed ID: 31078044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
    Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
    J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.